Korean joint research team have elucidated the overexpression of estrogen signaling pathways in specific Korean never-smoking lung cancer cases using multi-omics analysis and proposed the anti-cancer drug saracatinib as a targeted therapeutic agent.
High insulin levels contribute to worse outcomes for Black women compared to white women who have an aggressive form of breast cancer called triple-negative breast cancer, according to a study presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Exposure to increased neighborhood violence has the power to change the glucocorticoid receptor (GR) for the stress hormone, cortisol, which may influence the aggressiveness of lung cancer, according to data presented Sunday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass.
Almost one out of five breast cancer survivors may experience weight gain of more than 10%, suggests a study presented Monday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass. A number of factors are associated with excessive weight gain, the researchers found.
A new study led by researchers at the American Cancer Society (ACS) shows despite considerable growth in early palliative care (PC) use, utilization among patients with advanced cancer remained low from 2010 to 2019.
A new study led by researchers at the American Cancer Society (ACS) shows that older adult cancer survivors with excess body weight at the time of their first cancer diagnosis are at higher risk of developing a second cancer, especially an obesity-related cancer like breast or colorectal cancer.
A new “armored” form of CAR T cell therapy may be able to help patients with non-Hodgkin lymphoma whose cancers do not respond to currently available CAR T cell therapies. The Phase I clinical trial was presented at the 2024 ASCO Annual Meeting.
A new, large study led by researchers at the American Cancer Society (ACS) shows adults sticking to an exercise program of 15 or more metabolic equivalent hours (MET) of physical activity per week (300 or more minutes of moderate activity or 150 or more minutes of vigorous activity) decreased their risk for cancer, including obesity-related cancers, compared with no intervention.
Cancer health disparities are differences in cancer burden experienced by members of marginalized communities. As such, discrimination based on gender identity and/or sexual orientation contributes to cancer disparities today. While data about cancer among members of the LGBTQ+ community is somewhat limited, recent studies have found that members of this group may have an elevated rate of cancer diagnoses. Our experts share more.
A new study led by researchers at the American Cancer Society (ACS) shows increased disparities in survival by health insurance status among individuals newly diagnosed with advanced cancers in the United States following the introduction of immune checkpoint inhibitors (ICIs).
The American Cancer Society (ACS) and the American Society of Clinical Oncology (ASCO) today announced an expanded collaboration to make it simpler for patients to find authoritative cancer information online. The partnership between ASCO, the leading organization for cancer care providers, and ACS, the leading patient education, support, and advocacy organization in cancer, will create one of the largest and most comprehensive online resources for credible cancer information, available for free to the public on cancer.org.
Children who are sedentary for more than six waking hours a day have a significantly increased risk of severe fatty liver disease and liver cirrhosis by young adulthood, a new study finds. The research findings will be presented Saturday at ENDO 2024, the Endocrine Society’s annual meeting in Boston, Mass and published in Nature’s npj Gut and Liver.
Dana-Farber Cancer Institute researchers are leading 3 separate studies with encouraging results in treating patients with central nervous system (CNS) lymphoma, breast cancer, and glioblastoma. These findings are among more than 80 studies presented at ASCO that are led by Dana-Farber-affiliated researchers.
Clinicians at Georgetown University’s Lombardi Comprehensive Cancer Center reported promising preliminary findings based on outcomes in the first six patients with metastatic pancreatic cancer enrolled in a phase 2 clinical trial of the experimental drug BXCL701 in combination with the immunotherapy drug pembrolizumab (Keytruda).
In a first-of-its-kind study, the American Cancer Society (ACS) today released “Cancer in People who Identify as Lesbian, Gay, Bisexual, Transgender, Queer or Gender-nonconforming (LGBTQ+)”. The article provides the latest statistics on the prevalence of cancer screening and modifiable risk factors in LGBTQ+ populations, as well as a review of literature on cancer occurrence and obstacles to cancer prevention and treatment.
Astatine-211 is a promising alpha emitter for targeted alpha therapy for cancer, but astatine is among the least-studied elements. In this research, scientists investigated astatine’s behavior when interacting with ion exchange and extraction chromatography resins used to produce radioisotopes and delivering them to targets in the body.
Moffitt Cancer Center, a world-renowned cancer treatment and research center, and Virogen Biotechnology Inc., a clinical-stage biotechnology company, announced a groundbreaking strategic partnership today. This collaboration aims to propel the development of Virogen's cutting-edge fusion protein, VG712 (Resimmune), addressing significant unmet needs in oncology and immunotherapy.
Researchers from The University of Texas MD Anderson Cancer Center presented positive clinical results from two studies today at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting.
A team of researchers at Children’s Hospital Los Angeles recently published a genomic study that uncovered two classes of genetic causes for chordoma in children by conducting some genomic detective work.
Gastrointestinal cancer surgeons at the UC San Francisco have performed the health system’s 15,000th robotically assisted minimally invasive surgery, making it the first University of California health center to reach this milestone. UCSF Health has the busiest robotic surgery program in the UC health system and is the leading academic medical institution for robotic surgeries in the western U.S.
Showing results
1–20 of 24915
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
